 MARIETTA, Ga., Oct. 20, 2021 GLOBE NEWSWIRE -- MiMedx Group, Inc. Nasdaq: MDXG MIMEDX or the Company, an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that it will report operating and financial results for the third quarter ended September 30, 2021 after the market close on Tuesday, November 2, 2021. MIMEDX management will host a webcast and conference call to review its results on Wednesday, November 3, 2021, beginning at 8:30 am Eastern Time. 